Assessing Motor Imagery Ability of Tongue and Mouth in Subjects With and With no Temporomandibular Disorders (TMIQ)

Assessing Motor Imagery Using the Tongue and Mouth Imagery Questionnaire (TMIQ) in Patients With Temporomandibular Disorder and Healthy Control Subjects: a Reliability and Construct Validity Study

Temporomandibular disorder (TMD) is the symptomatic expression of a muscular or an articular impairment at the manducatory tract. TMD affects between 30 to 65% of the population with a higher prevalence for young women. The patients with DTM report a decrease of their personal, social and professional quality of life. Treatment usually relies on physical therapy. Among the different technics that can be used in physical therapy, there is growing evidence advocating the efficacy of using motor imagery (i.e. imagining a movement with no concomitant physical execution) during rehabilitation. It has also been shown that the benefits of practicing motor imagery depend on the ability (i.e., the higher the ability, the greater the benefits). However, there is no investigation of the motor imagery ability of the tongue and mouth movements conditioning the use of motor imagery during TMD rehabilitation. The objective of the study is to investigate the ability of imagining tongue and mouth movements using the Tongue and Mouth Imagery Questionnaire (TMIQ) as compare to the gold-standard Kinesthetic and Visual Imagery Questionnaire (KVIQ - Malouin et al., 2007).

Study Overview

Detailed Description

Principal objective:

Assess the validity construct of the Tongue and Mouth Imagery Questionnaire (TMIQ) as compare to the gold-standard Kinesthetic and Visual Imagery Questionnaire (KVIQ - Malouin et al., 2007), both measuring the motor imagery vividness.

Secondary objectives:

  1. Assess the reliability of the TMIQ using a test-retest.
  2. Assess the temporal coupling (i.e., the ratio between imagined and physically practiced movement) and compare these ratios for the TMIQ and KVIQ.
  3. Investigate the effect of TMD by comparing the vividness scores of TMIQ for respectively subject with and with no TMD.
  4. Investigate the effect of TMD by comparing the vividness scores of KVIQ for respectively subject with and with no TMD.
  5. Investigate the effect of TMD by comparing the temporal coupling scores of TMIQ for respectively subject with and with no TMD.
  6. Investigate the effect of TMD by comparing the temporal coupling scores of KVIQ for respectively subject with and with no TMD.

Study Type

Observational

Enrollment (Actual)

94

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69005
        • Cabinet Saint Alexandre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

47 participants with DTM 47 participants with no DTM (healthy control) age-matched and gender-matched to participants with DTM.

Description

Inclusion Criteria:

  • age between 18 and 75 years
  • A voluntary individual who has given informed consent after receiving clear, fair and appropriate information about the study.

For DTM group participants

  • inclusion during the DTM rehabilitation in the physical therapy firm "Cabinet Saint Alexandre".
  • beneficiary of the social security scheme

Exclusion Criteria:

  • The presence of a short tongue brake (Marchesan, 2005)
  • Lingual immaturity evaluated by the Tardieu test (Jouannaud et al. 1972)
  • Patients who had orthognathic surgery within 6 months post- operative, or facial fractures according to the same deadlines
  • The presence of peripheral facial palsy
  • Current participation in another research whose objective would be the evaluation of a therapeutic, drug or not, introducing an experimental bias.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Temporomandibular disorder group (TMD)

Patients with temporomandibular disorder coming at the Cabinet Saint Alexandre for orofacial rehabilitation.

Test 1: passation of the KVIQ questionnaire, followed by the passation of the TMIQ during a rehabilitation session supervised by the physical therapist (PT) Test 2: passation of the TMIQ during the next rehabilitation session supervised by the same PT(interval between PT session 1 and 2 is a maximum of 45 days).

Questionnaires were performed during the course of the patient rehabilitation that was instructed not to perform imagined movement during the interval.

comparison of the TMIQ to the gold-standard questionnaire (KVIQ) and test-retest
Control healthy group (CTL)

Healthy individuals with no temporomandibular disorder (i.e., no orofacial medical consultation or rehabilitation) aged-matched and gender-matched to TMD group.

Test 1: passation of the KVIQ questionnaire, followed by the passation of the TMIQ during a session supervised by the physical therapist (PT) Test 2: passation of the TMIQ during the next session supervised by the same PT(interval between PT session 1 and 2 is a maximum of 8 days).

Questionnaires were performed with no additional rehabilitation and participants were instructed not to perform imagined movement during the interval.

comparison of the TMIQ to the gold-standard questionnaire (KVIQ) and test-retest

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
vividness score of imagined movements of the TMIQ for the DTM group
Time Frame: at study inclusion, i.e day 1
Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group
at study inclusion, i.e day 1
vividness score of imagined movements of the TMIQ for the CTL group
Time Frame: at study inclusion, i.e day 1
Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group
at study inclusion, i.e day 1
vividness score of imagined movements of the KVIQ for the DTM group
Time Frame: at study inclusion, i.e day 1
Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the KVIQ for the DTM group
at study inclusion, i.e day 1
vividness score of imagined movements of the KVIQ for the CTL group
Time Frame: at study inclusion, i.e day 1
Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the KVIQ for the DTM group
at study inclusion, i.e day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
vividness score of imagined movements of the TMIQ for the DTM group
Time Frame: at study completion, between 8 days to 45 days after inclusion
Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group
at study completion, between 8 days to 45 days after inclusion
vividness score of imagined movements of the TMIQ for the CTL group
Time Frame: at study completion, between 8 days to 45 days after inclusion
Averaged vividness score (using a 5-point likert scale, 1=minimum vividness, 5=maximal vividness) for the TMIQ for the DTM group
at study completion, between 8 days to 45 days after inclusion
Temporal coupling to imagined movements of the TMIQ for the DTM group
Time Frame: at study completion, between 8 days to 45 days after inclusion
Computation of ratio between imagined and physically practiced movements measured during the TMIQ for the DTM group
at study completion, between 8 days to 45 days after inclusion
Temporal coupling to imagined movements of the TMIQ for the CTL group
Time Frame: at study inclusion, i.e day 1
Computation of ratio between imagined and physically practiced movements measured during the TMIQ for the DTM group
at study inclusion, i.e day 1
Temporal coupling to imagined movements of the TMIQ for the CTL group
Time Frame: at study completion, between 8 days to 45 days after inclusion
Computation of ratio between imagined and physically practiced movements measured during the TMIQ for the DTM group
at study completion, between 8 days to 45 days after inclusion

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
mental representation of the maximal opening of the mouth for the DTM group
Time Frame: at study inclusion, i.e day 1
comparison of the score (5-point likert Scale, 1= minimal opening, 5=maximal opening) self-reported by the participant after imagination of maximal mouth opening as compared to the score of the physical therapist after the physical execution of mouth opening by the participant during the TMIQ for the DTM group
at study inclusion, i.e day 1
mental representation of the maximal opening of the mouth for the CTL group
Time Frame: at study inclusion, i.e day 1
comparison of the score (5-point likert Scale, 1= minimal opening, 5=maximal opening) self-reported by the participant after imagination of maximal mouth opening as compared to the score of the physical therapist after the physical execution of mouth opening by the participant during the TMIQ for the CTL group
at study inclusion, i.e day 1
Accuracy of tongue pointing against the wood examination stick for the DTM group
Time Frame: at study inclusion, i.e day 1
Measure the surface of the tongue print after that participant was requested to point as accurately as possible while keeping the tongue sharp against the wood examination stick for the DTM group
at study inclusion, i.e day 1
Accuracy of tongue pointing against the wood examination stick for the CTL group
Time Frame: at study inclusion, i.e day 1
Measure the surface of the tongue print after that participant was requested to point as accurately as possible while keeping the tongue sharp against the wood examination stick for the CTL group
at study inclusion, i.e day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Caroline Alvarado-Faysse, PT, Cabinet de kinésithérapie Saint Alexandre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 26, 2018

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

September 19, 2019

First Submitted That Met QC Criteria

September 21, 2019

First Posted (Actual)

September 25, 2019

Study Record Updates

Last Update Posted (Actual)

March 6, 2020

Last Update Submitted That Met QC Criteria

March 4, 2020

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Disorder

Clinical Trials on reliability and validity construct of the TMIQ

3
Subscribe